FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006308858> ?p ?o ?g. }

• W2006308858 endingPage "1828" @default.
• W2006308858 startingPage "1821" @default.
• W2006308858 abstract "A single-institution, randomized open trial was prospectively performed to compare orally administered granisetron with or without intramuscularly administered methylprednisolone to metoclopramide plus methylprednisolone in the prevention of delayed nausea and vomiting induced by cisplatin-based chemotherapy. The effects of antiemetic treatments were evaluated from days 2 to 5 of the first cycle after cisplatin administration among patients who had never before received chemotherapy.All patients were treated with chemotherapeutic regimens containing cisplatin greater than or equal to 80 mg/m2 and received antiemetic therapy with granisetron 3 mg intravenously for the control of acute emesis. Patients who responded to treatment during the first 24 hours were randomized to receive (1) metoclopramide (0.5 mg/kg) intramuscularly three times daily plus methylprednisolone (125 mg) intramuscularly once a day or (2) granisetron (1 mg) orally twice daily or (3) oral granisetron (1 mg) orally plus methylprednisolone (125 mg) intramuscularly from days 2 to 5.Of the patients treated with metoclopramide plus methylprednisolone (n = 92), 53% had complete protection from delayed emesis, 16% a major response, 15% a minor response, and 15% no response. Of the patients treated with granisetron alone (n = 84), 33% had a complete response, 21% a major response, 23% a minor response, and 21% no response. In the patients treated with orally administered granisetron plus intramuscularly administered methylprednisolone (n = 86), 47% had a complete response, 17% a major response, 23% a minor response, and 13% no response. These differences reached statistical significance only when the complete response rate achieved in the metoclopramide plus methylprednisolone group was compared with that recorded in the oral granisetron group (P = 0.012). Moreover, the metoclopramide plus methylprednisolone and the orally administered granisetron plus corticosteroid arms were superior to the orally administered granisetron alone arm in preventing nausea (P < 0.038 and P < 0.002, respectively). No extrapyramidal side effects were noted for the granisetron alone and the granisetron plus methylprednisolone arms, whereas 6% of patients treated with metoclopramide had extrapyramidal adverse effects. Headache was recorded in 8% of patients treated with granisetron alone, in 9% treated with granisetron plus methylprednisolone, and in 3% treated with metoclopramide plus methylprednisolone.These data suggest that orally administered granisetron with or without methylprednisolone may be given safely to patients with cancer as prophylactic therapy against delayed emesis after high dose cisplatin therapy. Orally administered granisetron alone was less active than a standard combination of metoclopramide plus methylprednisolone. However, the addition of corticosteroid to orally administered granisetron improved the control of delayed emesis. The efficacy of the combination of metoclopramide plus methylprednisolone and oral granisetron with or without methylprednisolone against delayed emesis still is not entirely satisfactory." @default.
• W2006308858 created "2016-06-24" @default.
• W2006308858 creator A5009819935 @default.
• W2006308858 creator A5013748999 @default.
• W2006308858 creator A5036592189 @default.
• W2006308858 creator A5050262758 @default.
• W2006308858 creator A5081291949 @default.
• W2006308858 creator A5086693219 @default.
• W2006308858 date "1995-11-15" @default.
• W2006308858 modified "2023-10-14" @default.
• W2006308858 title "Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial" @default.
• W2006308858 cites W1825683585 @default.
• W2006308858 cites W1866325220 @default.
• W2006308858 cites W1964085379 @default.
• W2006308858 cites W1984347015 @default.
• W2006308858 cites W1984568013 @default.
• W2006308858 cites W1995925329 @default.
• W2006308858 cites W1996988130 @default.
• W2006308858 cites W2002415299 @default.
• W2006308858 cites W2010246512 @default.
• W2006308858 cites W2042926768 @default.
• W2006308858 cites W2047833151 @default.
• W2006308858 cites W2058276045 @default.
• W2006308858 cites W2058511378 @default.
• W2006308858 cites W2058678881 @default.
• W2006308858 cites W2059700850 @default.
• W2006308858 cites W2077172607 @default.
• W2006308858 cites W2086295931 @default.
• W2006308858 cites W2120222259 @default.
• W2006308858 cites W2133461420 @default.
• W2006308858 cites W2154742149 @default.
• W2006308858 cites W2229057528 @default.
• W2006308858 doi "https://doi.org/10.1002/1097-0142(19951115)76:10<1821::aid-cncr2820761022>3.0.co;2-y" @default.
• W2006308858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8625054" @default.
• W2006308858 hasPublicationYear "1995" @default.
• W2006308858 type Work @default.
• W2006308858 sameAs 2006308858 @default.
• W2006308858 citedByCount "26" @default.
• W2006308858 countsByYear W20063088582020 @default.
• W2006308858 crossrefType "journal-article" @default.
• W2006308858 hasAuthorship W2006308858A5009819935 @default.
• W2006308858 hasAuthorship W2006308858A5013748999 @default.
• W2006308858 hasAuthorship W2006308858A5036592189 @default.
• W2006308858 hasAuthorship W2006308858A5050262758 @default.
• W2006308858 hasAuthorship W2006308858A5081291949 @default.
• W2006308858 hasAuthorship W2006308858A5086693219 @default.
• W2006308858 hasBestOaLocation W20063088581 @default.
• W2006308858 hasConcept C141071460 @default.
• W2006308858 hasConcept C2776694085 @default.
• W2006308858 hasConcept C2777452722 @default.
• W2006308858 hasConcept C2778479196 @default.
• W2006308858 hasConcept C2780372218 @default.
• W2006308858 hasConcept C2780580376 @default.
• W2006308858 hasConcept C2780852908 @default.
• W2006308858 hasConcept C2780884295 @default.
• W2006308858 hasConcept C42219234 @default.
• W2006308858 hasConcept C71924100 @default.
• W2006308858 hasConceptScore W2006308858C141071460 @default.
• W2006308858 hasConceptScore W2006308858C2776694085 @default.
• W2006308858 hasConceptScore W2006308858C2777452722 @default.
• W2006308858 hasConceptScore W2006308858C2778479196 @default.
• W2006308858 hasConceptScore W2006308858C2780372218 @default.
• W2006308858 hasConceptScore W2006308858C2780580376 @default.
• W2006308858 hasConceptScore W2006308858C2780852908 @default.
• W2006308858 hasConceptScore W2006308858C2780884295 @default.
• W2006308858 hasConceptScore W2006308858C42219234 @default.
• W2006308858 hasConceptScore W2006308858C71924100 @default.
• W2006308858 hasIssue "10" @default.
• W2006308858 hasLocation W20063088581 @default.
• W2006308858 hasLocation W20063088582 @default.
• W2006308858 hasOpenAccess W2006308858 @default.
• W2006308858 hasPrimaryLocation W20063088581 @default.
• W2006308858 hasRelatedWork W1571123878 @default.
• W2006308858 hasRelatedWork W1768571168 @default.
• W2006308858 hasRelatedWork W2020495947 @default.
• W2006308858 hasRelatedWork W2036556714 @default.
• W2006308858 hasRelatedWork W2052288686 @default.
• W2006308858 hasRelatedWork W2348573567 @default.
• W2006308858 hasRelatedWork W2352188955 @default.
• W2006308858 hasRelatedWork W2371441693 @default.
• W2006308858 hasRelatedWork W4226239113 @default.
• W2006308858 hasRelatedWork W2977817246 @default.
• W2006308858 hasVolume "76" @default.
• W2006308858 isParatext "false" @default.
• W2006308858 isRetracted "false" @default.
• W2006308858 magId "2006308858" @default.
• W2006308858 workType "article" @default.